A 49-year-old woman has been on semaglutide for five months. She lost twelve pounds in the first three months and then stopped responding. Her appetite is still suppressed, she is eating about 1,400 calories a day, she is lifting twice a week, and the scale has not moved since week 14. She is also exhausted, sleeping poorly, foggy in the afternoons, and has noticed her hair is shedding more than it used to. The clinic that started her on the GLP-1 told her to "be patient" and offered to titrate her dose up.
I see this in patients constantly, and the answer is almost never to push the GLP-1 dose higher. The plateau is not a GLP-1 problem. It is a perimenopausal hormone problem that the GLP-1 alone was never going to fix, layered on top of a thyroid that has likely shifted as estrogen has declined. When I evaluate someone in this position, the question is not how to get her to lose more weight on GLP-1. The question is what other levers we need to pull, and in what order, to get her body composition moving again.
Why GLP-1 alone plateaus in mid-life women
GLP-1 receptor agonists do three things mechanically: they slow gastric emptying, they suppress appetite at the brain level (acting on the hypothalamic appetite centers), and they improve insulin sensitivity at the muscle and liver. Across study populations, semaglutide produces about 15% body weight loss over 68 weeks and tirzepatide about 21%. Those numbers are real, but they are averages, and the averages mask the patients who plateau early because the medication is addressing one mechanism while two or three others are silently working against them.
For a perimenopausal woman, the mechanisms that GLP-1 does not touch are the ones that are usually driving the plateau:
- Declining estradiol shifts fat distribution toward visceral adiposity and reduces resting metabolic rate by 50-100 calories per day independent of body weight
- Declining progesterone disrupts sleep architecture, and disrupted sleep produces measurable insulin resistance and elevated cortisol the next day
- Declining testosterone (yes, women need testosterone too — typical optimal range is 40-70 ng/dL total) reduces lean mass over time and reduces the ability to build new muscle in response to training
- Subclinical thyroid dysfunction often emerges or worsens as estrogen drops, and impaired T4-to-T3 conversion lowers basal metabolic rate further
- Cortisol dysregulation from sleep disruption and life stress (which the perimenopausal woman is usually carrying in spades) directly promotes visceral fat storage
Suppressing appetite while these other mechanisms are unaddressed produces exactly the pattern I see in the clinic: early loss followed by plateau, often with worsening fatigue, mood, and sometimes hair shedding because the calorie deficit is happening on top of inadequate hormonal support.
What the combined workup looks like
When a woman comes in already on GLP-1 with a plateau, or considering GLP-1 for the first time as a perimenopausal patient, the workup I run is the full picture. Standard metabolic markers — fasting insulin, HbA1c, fasting glucose, lipid panel, comprehensive metabolic panel, hs-CRP. Full sex hormone panel — estradiol, progesterone, total and free testosterone, SHBG, DHEA-S, FSH. Full thyroid panel — TSH, free T4, free T3, reverse T3, anti-TPO, anti-thyroglobulin. Ferritin and vitamin D. Cortisol pattern (four-point salivary or AM serum with context) when the symptom picture suggests dysregulation.
What I look for:
- Estradiol below 50 pg/mL in a symptomatic woman — that is the hormone level driving the body composition shift
- Progesterone deficiency on day-21 testing (or any day for a woman without cycles) — drives the sleep disruption
- Free testosterone in the bottom quartile — drives the loss of lean mass
- Free T3 in the bottom quartile or reverse T3 elevated — drives the basal metabolic rate suppression
- SHBG elevated — often by oral estrogen if she is already on it via the wrong route, or by chronic caloric restriction, which is its own cause of plateau
The picture that emerges almost always has at least two of these elements present. The plan that breaks the plateau addresses them in sequence rather than throwing everything at the patient at once.
How I sequence the combined protocol
Sequencing matters because changing too many variables at the same time means we cannot tell what is working. My general framework for the combined medical weight loss program plus hormone optimization patient:
Weeks 1-4: Optimize the GLP-1 dose if she is already on it (sometimes that means going down, not up — patients on too high a dose lose muscle and stall). Initiate hormone optimization with the most clinically obvious deficiency first — usually estradiol via patch or pellet, plus oral micronized progesterone if the uterus is intact. Set the protein target — 0.8 to 1.0 grams per pound of goal body weight, which on a suppressed appetite means deliberate, structured intake. Nutritional counseling is built in here because the patient has to actually hit the protein number; estimating does not work.
Not sure where to start?
The Start Here pathway walks you through the most common entry points and helps you decide which consultation type is the right fit. Five minutes of self-assessment can save you a wrong-direction conversation.
Weeks 4-8: Add testosterone if it was below the functional threshold. Address thyroid if T3 was suboptimal — sometimes a low-dose T3 addition, sometimes coordination with her existing endocrinologist if she is already on levothyroxine. Reassess sleep — most patients on bioidentical progesterone start sleeping better within two weeks, which by week 6 is usually showing up in cortisol and morning energy.
Weeks 8-12: Body composition reassessment, ideally by DEXA, to confirm we are losing fat and preserving or gaining lean mass. Lab redraw on hormones at the eight-week mark to confirm levels are in the optimal range. Adjust based on data. Begin the maintenance-plan conversation — what does this look like at six months, at twelve months, at three years.
The pattern I see when this is sequenced correctly: the plateau breaks, often in the second or third week of hormone optimization, and the next 8-12 pounds come off without the appetite suppression being the only thing driving the loss. More importantly, body composition shifts in the right direction — fat down, lean mass preserved or up.
Who is a candidate for the combined approach — and who is not
Good candidates in my practice:
- Perimenopausal or postmenopausal women with central adiposity, suboptimal hormone labs, and a symptom cluster consistent with the hormonal picture (sleep, mood, energy, libido, body composition)
- Women who have already tried GLP-1 alone and plateaued, and whose lab work confirms hormonal contributors
- Men with low testosterone and central adiposity (the male version of this article addresses that picture in detail)
- Patients who can commit to the reassessment cadence — at 8 weeks, at 12 weeks, at 6 months, at 12 months
Less-good candidates — and I do turn people away:
- Patients whose primary problem is unaddressed sleep apnea, real alcohol use disorder, or untreated mood disorder that is driving the eating pattern
- Patients with absolute contraindications to either component (active thromboembolic disease for estrogen, active estrogen-receptor-positive breast cancer for estrogen, medullary thyroid carcinoma history for GLP-1, untreated severe gastroparesis for GLP-1)
- Patients seeking immediate transformation who will not commit to the 90-day structured phase plus follow-up
The men who come into the practice with a long cardiovascular family history get a particular flavor of conversation given my background — 17 years in emergency medicine, cardiac ICU, and the cath lab means I have spent a lot of time with the men this demographic produces when nothing is addressed. Combined hormone optimization and weight management has cardiovascular implications that have to be weighed honestly.
What realistic outcomes look like
A perimenopausal woman who runs the full combined protocol — GLP-1 (when indicated) plus estradiol plus progesterone plus testosterone (when indicated) plus structured protein and resistance training plus thyroid optimization where the labs warrant it — typically loses 12-18% of body weight over the first six months while preserving or gaining lean mass, and reports meaningful improvement in sleep, mood, energy, and cognitive function within the first 8 weeks of hormone initiation.
The same woman on GLP-1 alone, with the hormonal picture unaddressed, typically loses 8-10% over the same window with progressive loss of lean mass, persistent fatigue, and a high probability of plateau by month 4.
What I tell patients honestly: combined therapy is not faster in terms of pounds per week. It is more durable, it preserves the body composition you actually want, and it addresses the symptom picture that the GLP-1 was never going to fix. The patients who run the combined protocol are usually still happy with their outcome at month 12. The patients who run GLP-1 alone often regain by month 18 because the underlying physiology never changed.
The next step
If you are in middle Georgia — Columbus, Warner Robins, Fort Benning area — and you are either considering combined weight loss and hormone therapy or you have plateaued on GLP-1 alone, the next step is a comprehensive workup that addresses both pictures together rather than separately.
Book a weight loss assessment to get oriented, then online booking for a consultation at the Columbus clinic or Warner Robins clinic. Bring any prior labs (especially any GLP-1 dosing history and any hormone work), the list of what has and has not worked, and the symptoms beyond weight that have been bothering you. We will start with the data and build a plan that addresses the actual physiology — not just the appetite.
Medical disclaimer: This article is for educational purposes only and does not constitute medical advice. Individual clinical decisions should be made in consultation with a qualified healthcare provider following appropriate evaluation. References to specific treatments, dosing, or protocols are informational.
Travis spent 17+ years in high-acuity clinical medicine — emergency, cardiac ICU, and cath lab — before founding Revitalize. He is a Certified Platinum Biote hormone therapy provider, the published author of You're Not Broken — You're Unbalanced, and the founder of the Rebuild Metabolic Health Institute. His clinical writing reflects the same precision he brought to critical care: specific, honest, and built around what actually works.
Ready to talk it through with a clinician?
Book online or call either Georgia location. Every visit starts with a consultation.